Expression and regulation of INTELECTIN1 in human granulosa-lutein cells: role in IGF-1-induced steroidogenesis through NAMPT

• Published in: Biology of reproduction Vol. 91; no. 2; p. 50
• Main Authors: Cloix, Lucie, Reverchon, Maxime, Cornuau, Marion, Froment, Pascal, Ramé, Christelle, Costa, Caroline, Froment, Gisèle, Lecomte, Pierre, Chen, Wenyong, Royère, Dominique, Guerif, Fabrice, Dupont, Joëlle
• Format: Journal Article
• Language: English
• Published: United States Society for the Study of Reproduction - Oxford Academic 01.08.2014
• Subjects: Adult; AMP-Activated Protein Kinases - genetics; AMP-Activated Protein Kinases - metabolism; Aromatase - genetics; Aromatase - metabolism; Cytokines - genetics; Cytokines - metabolism; Estradiol - biosynthesis; Female; Follicle Stimulating Hormone - pharmacology; Gene Expression Regulation - drug effects; Gene Knockdown Techniques; GPI-Linked Proteins - genetics; GPI-Linked Proteins - metabolism; Humans; Hypoglycemic Agents - pharmacology; Insulin Receptor Substrate Proteins - genetics; Insulin Receptor Substrate Proteins - metabolism; Insulin-Like Growth Factor I - pharmacology; Lectins - genetics; Lectins - metabolism; Life Sciences; Luteal Cells - metabolism; Luteinizing Hormone - pharmacology; Metformin - pharmacology; Mitogen-Activated Protein Kinase Kinases - genetics; Mitogen-Activated Protein Kinase Kinases - metabolism; Nicotinamide Phosphoribosyltransferase - genetics; Nicotinamide Phosphoribosyltransferase - metabolism; Other; Receptor, IGF Type 1 - genetics; Receptor, IGF Type 1 - metabolism; Reproductive Biology; RNA, Messenger - genetics; RNA, Messenger - metabolism; Steroids - biosynthesis; PCOS; ovary; signaling pathways; adipokine; NAMPT; fertility; IGF-1; pcos; nampt; signaling pathway; igf 1
• ISSN: 1529-7268; 0006-3363; 1529-7268
• DOI: 10.1095/biolreprod.114.120410

INTELECTIN (ITLN) is an adipokine involved in the regulation of insulin sensitivity and inflammatory and immunity responses. Serum ITLN levels are lower in obese, diabetic, and polycystic ovary syndrome (PCOS) women than in control subjects. ITLN has never been studied in ovarian cells. Here, we identified ITLN1 in human ovarian follicles and investigated the molecular mechanisms involved in the regulation of its expression in response to the insulin sensitizers metformin and rosiglitazone, in human granulosa-lutein cells (hGLCs) and in a human ovarian granulosa-like tumor cell line (KGN). We also studied the effects of human recombinant ITLN1 (hRom1) on steroid production and on the activation of various signaling pathways. Using RT-PCR, immunoblotting, and immunohistochemistry, we found that INTL1 is present in human follicular cells. Using ELISA, we showed that INTL levels are similar in plasma and follicular fluid (FF) in control patients, whereas they are higher in FF than in plasma in PCOS patients. In KGN cells and hGLCs, insulin (10(-8) M), insulin-like growth factor-1 (IGF-1; 10(-8) M), and metformin (10(-2) M or 10(-3) M) increased INTL1 expression (mRNA and protein) after 12 and 24 h of stimulation. For metformin, this effect was mediated by adenosine monophosphate-activated kinase (PRKA). Furthermore, hRom1 increased nicotinamide phosphoribosyltransferase (NAMPT) expression in KGN and hGLCs. We also showed that hRom1 increased IGF-1-induced progesterone and estradiol secretion and this was associated with an increase in the STAR and CYP19A1 protein levels and an increase in IGF-1R signaling. Furthermore, all these data were abolished when NAMPT was knocked down in KGN cells, suggesting that INTL1 improves IGF-1-induced steroidogenesis through induction of NAMPT in hGLCs.